We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Open-Irrigated Catheter Aids Treatment of Atrial Flutter

By HospiMedica International staff writers
Posted on 28 Mar 2016
Print article
The Blazer open-irrigated RF ablation catheter
The Blazer open-irrigated RF ablation catheter (Photo courtesy of Boston Scientfic )
A novel radiofrequency (RF) ablation catheter provides an elegant cooling platform for treating atrial flutter (AF), with robust handling capabilities.

The Blazer open-irrigated (OI) RF ablation catheter is indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, and RF ablation of sustained or recurrent type 1 AF in adult patients. Contraindications include patients with an active systemic infection; those with a mechanical prosthetic heart valve; patients unable to receive heparin or an alternative anticoagulant; patients who have vena cava embolic protection filter devices; those who are hemodynamically unstable; and those who have myxoma or an intracardiac thrombus.

The ablation catheter features bidirectional steering, predictable trackability and torqueability, fine micromovement, and high tip stability and contact. A unique feature is Total Tip cooling, a technology to cool the catheter tip consistently during the procedure, thus improving the quality of the ablation lesion. The Blazer OI ablation catheter is intended for use with the Maestro 4000 RF Controller and the MetriQ irrigation pump, and is available with a range of tip curve styles, including standard, large, extra-long, and asymmetric. The Blazer OI ablation catheter is a product of Boston Scientific (Natick, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The Blazer open-irrigated catheter is safe and effective for the ablation of atrial flutter," said Prof. Tom McElderry, MD, section chief of electrophysiology at the University of Alabama at Birmingham (UAB; USA), who participated in the BLOCk-CTI clinical trial of the device. “This newly approved ablation tool was built on the proven Blazer platform of therapeutic catheters and facilitates excellent maneuverability, consistent cooling, and stability during procedures.”

Cardiac ablation is a procedure that is used to correct structural problems in the heart by scarring or destroying tissue that triggers an abnormal heart rhythm, especially supraventricular tachyarrhythmias such as AF, atrial fibrillation, and atrial tachycardia. The low-risk procedure takes 2–4 hours and is most often performed in an electrophysiology or a cardiac catheterization lab. It is successful in about 90% of the people who have it.

Related Links:

Boston Scientific


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Plasma Freezer
iBF125-GX
New
Documentation System For Blood Banks
HettInfo II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.